Title : Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2.

Pub. Date : 2018 Jun 14

PMID : 29792703






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Abiraterone is a clinical first-in-class inhibitor of cytochrome P450 17A1 (CYP17A1) required for androgen biosynthesis. abiraterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 Abiraterone is a clinical first-in-class inhibitor of cytochrome P450 17A1 (CYP17A1) required for androgen biosynthesis. abiraterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
3 Abiraterone analogs were designed based on structural evidence that B-ring substituents may favorably interact with polar residues in binding CYP17A1 and sterically clash with residues in the CYP21A2 active site. abiraterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens